Valuation: Kenvue Inc.

Market Cap 36.94B 31.95B 29.84B 27.37B 51.48B 3,515B 52.3B 350B 137B 1,762B 139B 136B 5,825B P/E 2026 *
20.2x
P/E 2027 * 17.8x
Enterprise Value 44B 38.06B 35.54B 32.61B 61.33B 4,188B 62.3B 417B 164B 2,099B 165B 162B 6,939B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.73x
Free-Float
98.86%
Yield 2026 *
4.39%
Yield 2027 * 4.48%
1 day+0.26%
1 week-0.05%
Current month-0.05%
1 month-0.31%
3 months+9.32%
6 months+6.07%
Current year+11.48%
1 week 18.68
Extreme 18.685
19.7
1 month 18.58
Extreme 18.58
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.96
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.26%-0.05%-9.89%-17.75% 36.94B
-0.80%+0.90%-5.03%-7.19% 339B
-0.83%-1.54%-7.77%+1.56% 136B
+0.29%+2.16%+10.13%+22.19% 74.35B
+0.79%-0.25%-16.11%-18.31% 51.75B
+3.35%+5.30%-2.58%-47.45% 31.96B
+1.58%+11.81%+6.11%+27.63% 20.96B
-0.88%+0.59%-19.32%-32.14% 20.47B
+0.14%+1.80%+15.56%+9.89% 20.18B
-2.53%-1.91%-11.47%+4.02% 11.29B
Average +0.14%+2.00%-4.04%-5.76% 74.25B
Weighted average by Cap. -0.29%+1.47%-4.54%-4.75%

Financials

2026 *2027 *
Net sales 15.6B 13.5B 12.6B 11.56B 21.75B 1,485B 22.09B 148B 58.04B 744B 58.6B 57.31B 2,461B 15.99B 13.83B 12.92B 11.85B 22.29B 1,522B 22.64B 152B 59.49B 763B 60.05B 58.74B 2,522B
Net income 1.83B 1.58B 1.48B 1.36B 2.55B 174B 2.59B 17.36B 6.81B 87.39B 6.88B 6.73B 289B 2.09B 1.8B 1.68B 1.55B 2.91B 198B 2.95B 19.76B 7.76B 99.47B 7.83B 7.66B 329B
Net Debt 7.07B 6.11B 5.71B 5.24B 9.85B 672B 10B 66.96B 26.28B 337B 26.53B 25.95B 1,114B 6.75B 5.84B 5.45B 5B 9.41B 643B 9.56B 64B 25.12B 322B 25.36B 24.8B 1,065B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-07 US$19.23 +0.26% 14,325,931
26-08-06 US$19.18 -2.49% 25,328,494
26-08-05 US$19.67 +0.61% 32,808,027
26-08-04 US$19.55 +2.84% 23,595,514
26-08-03 US$19.01 -1.20% 35,167,488
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.23USD
Average target price
19.67USD
Spread / Average Target
+2.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock